Pharma, healthcare sector mutual funds deliver up to 44% return in 2024. Should you increase allocation?

November 5, 2024

Pharma and healthcare mutual funds have yielded impressive returns in 2024. The sector benefited from resilience amidst corrections in other sectors and steady growth in the domestic market. Experts suggest a cautious approach to investment due to current valuations. A phased allocation strategy of 10-15% is recommended, with potential for increasing allocation over time.

More To Explore

Just Dial Q3 results: PAT jumps 43% YoY to Rs 131 crore, revenue up 8%

Just Dial reported a 43% YoY rise in Q3FY25 net profit to ₹131.31 crore, with revenue up 8.4% to ₹287.33 crore. Sequentially, profit declined 15%.

January 10, 2025

34 mutual fund NFOs mobilised Rs 13,852 crore in December

In December, 34 mutual fund NFOs raised Rs 13,852 crore, with 33 open-ended and one close-ended fund. Sectoral and thematic funds led with Rs 11,337

January 10, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003